{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:22:54Z","timestamp":1793395374726,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40121-020-00395-2","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T10:05:04Z","timestamp":1611569104000},"page":"75-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":183,"title":["Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria"],"prefix":"10.1007","volume":"10","author":[{"given":"Glen T.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"395_CR1","first-page":"445","volume":"181","author":"P Ehrlich","year":"1913","unstructured":"Ehrlich P. Address in pathology on chemotherapeutics: scientific principles, methods and results. Lancet. 1913;181:445\u201351.","journal-title":"Lancet"},{"key":"395_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/146837a0","volume":"46","author":"E Abraham","year":"1940","unstructured":"Abraham E, Chain E. An enzyme from bacteria able to destroy penicillin. Nature. 1940;46:837.","journal-title":"Nature"},{"key":"395_CR3","first-page":"3","volume":"42","author":"EP Abraham","year":"1992","unstructured":"Abraham EP, Chain E, Fletcher CM, et al. Further observations on penicillin. Eur J Clin Pharmacol. 1992;42:3\u20139.","journal-title":"Eur J Clin Pharmacol."},{"key":"395_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-micro-090110-102911","volume":"65","author":"K Bush","year":"2010","unstructured":"Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new \u03b2-lactamases from gram-negative bacteria. Annu Rev Microbiol. 2010;65:455\u201378.","journal-title":"Annu Rev Microbiol."},{"key":"395_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush K, Jacoby GA. Updated functional classification of \u03b2-lactamases. Antimicrob Agents Chemother. 2010;54:969\u201376.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0065-2911(08)60376-8","volume":"9","author":"MH Richmond","year":"1973","unstructured":"Richmond MH, Sykes RB. The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol. 1973;9:31\u201388.","journal-title":"Adv Microb Physiol."},{"key":"395_CR7","doi-asserted-by":"crossref","unstructured":"Datta N, Kontomichalou P. Penicillinase synthesis controlled by infectious R factors in enterobacteriaceae. Nature 1965:239\u2013241.","DOI":"10.1038\/208239a0"},{"key":"395_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF01641355","volume":"11","author":"H Knothe","year":"1983","unstructured":"Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315\u20137.","journal-title":"Infection"},{"key":"395_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/CMR.00037-09","volume":"23","author":"SM Drawz","year":"2010","unstructured":"Drawz SM, Bonomo RA. Three decades of \u03b2-lactamase inhibitors. Clin Microbiol Rev. 2010;23:160\u2013201.","journal-title":"Clin Microbiol Rev"},{"key":"395_CR10","first-page":"13","volume":"309","author":"L Surgers","year":"2018","unstructured":"Surgers L, Boersma P, Girard P-M, et al. Molecular epidemiology of ESBL-producing E. coli and K. pneumoniae: establishing virulence clusters. Infect Drug Resist. 2018;309:13\u20138.","journal-title":"Infect Drug Resist."},{"key":"395_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12917-019-2011-9","volume":"15","author":"CM Isgren","year":"2019","unstructured":"Isgren CM, Edwards T, Pinchbeck GL, et al. Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008\u20132017). BMC Vet Res. 2019;15:268.","journal-title":"BMC Vet Res."},{"key":"395_CR12","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215:S28\u201336.","journal-title":"J Infect Dis."},{"key":"395_CR13","first-page":"42","volume":"74","author":"L Gauthier","year":"2019","unstructured":"Gauthier L, Dortet L, Jousset AB, et al. Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae. J Antimicrob Chemother. 2019;74:42\u20137.","journal-title":"J Antimicrob Chemother."},{"key":"395_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/AAC.00783-09","volume":"54","author":"M Tato","year":"2010","unstructured":"Tato M, Coque TM, Baquero F, Cant\u00f3n R. Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010;54:320\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K. Carbapenemases: the versatile \u03b2-lactamases. Clin Microbiol Rev. 2007;20:440\u201358.","journal-title":"Clin Microbiol Rev."},{"key":"395_CR16","doi-asserted-by":"publisher","first-page":"249856","DOI":"10.1155\/2014\/249856","volume":"2014","author":"L Dortet","year":"2014","unstructured":"Dortet L, Poirel L, Nordmann P. Worldwide dissemination of the NDM-type carbapenemases in gram-negative bacteria. Biomed Res Int. 2014;2014:249856.","journal-title":"Biomed Res Int."},{"key":"395_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","volume":"29","author":"R Potter","year":"2016","unstructured":"Potter R, D\u2019Souza A, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Drug Resist Updat. 2016;29:30\u201346.","journal-title":"Drug Drug Resist Updat."},{"key":"395_CR18","doi-asserted-by":"crossref","unstructured":"Nordman P, L. P. he difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 2014; 20:821\u2013830.","DOI":"10.1111\/1469-0691.12719"},{"key":"395_CR19","doi-asserted-by":"crossref","unstructured":"Tada T, Nhung P, Miyoshi-Akiyama T, et al. IMP-51, a novel IMP-type metallo-\u03b2-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. 2015; 59:7090\u20137093.","DOI":"10.1128\/AAC.01611-15"},{"key":"395_CR20","doi-asserted-by":"crossref","unstructured":"H. Y, A K, R O, H K, T K, M. I. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001; 45:1343\u20131348.","DOI":"10.1128\/AAC.45.5.1343-1348.2001"},{"key":"395_CR21","unstructured":"S K, T S, N K, T I-H, M T, Y Y. No Title. Antimicrob Agents Chemother 2017; 6:eoo576\u201317."},{"key":"395_CR22","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1128\/AAC.01458-05","volume":"50","author":"AJ Schmidtke","year":"2006","unstructured":"Schmidtke AJ, Hanson ND. Model system to evaluate the effect of ampD mutations on AmpC-mediated \u03b2-lactam resistance. Antimicrob Agents Chemother. 2006;50:2030\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR23","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1128\/AAC.01729-15","volume":"59","author":"F Gu\u00e9rin","year":"2015","unstructured":"Gu\u00e9rin F, Isnard C, Cattoir V, Giard JC. Complex regulation pathways of AmpC-mediated \u03b2-lactam resistance in Enterobacter cloacae complex. Antimicrob Agents Chemother. 2015;59:7753\u201361.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA. AmpC -Lactamases. Clin Microbiol Rev. 2009;22:161\u201382.","journal-title":"Clin Microbiol Rev."},{"key":"395_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1099\/jmm.0.2008\/002774-0","volume":"57","author":"M Pavez","year":"2008","unstructured":"Pavez M, Neves P, Dropa M, et al. Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil. J Med Microbiol. 2008;57:1590\u20132.","journal-title":"J Med Microbiol."},{"key":"395_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","volume":"48","author":"L Poirel","year":"2004","unstructured":"Poirel L, H\u00e9ritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:15\u201322.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/jac\/dks121","volume":"67","author":"L Poirel","year":"2012","unstructured":"Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67:1597\u2013606.","journal-title":"J Antimicrob Chemother."},{"key":"395_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.chembiol.2009.04.010","volume":"16","author":"J-D Docquier","year":"2009","unstructured":"Docquier J-D, Calderone V, De Luca F, et al. Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases. Chem Biol. 2009;16:540\u20137.","journal-title":"Chem Biol."},{"key":"395_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/JCM.02580-12","volume":"51","author":"AJ Mathers","year":"2013","unstructured":"Mathers AJ, Hazen KC, Carroll J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the \u2018menace\u2019 arrives in the new world. J Clin Microbiol. 2013;51:680\u20133.","journal-title":"J Clin Microbiol."},{"key":"395_CR30","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1128\/AAC.00565-15","volume":"59","author":"L Chen","year":"2015","unstructured":"Chen L, Al Laham N, Chavda KD, et al. First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza. Palestine Antimicrob Agents Chemother. 2015;59:4305\u20137.","journal-title":"Palestine Antimicrob Agents Chemother."},{"key":"395_CR31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J Infect Dis. 2008;197:1079\u201381.","journal-title":"J Infect Dis."},{"key":"395_CR32","unstructured":"CDC. https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf. 2013: 1\u201312."},{"key":"395_CR33","doi-asserted-by":"crossref","unstructured":"Yigit H, Biddle JW, Alberti S, et al (2002) Novel carbapenem-hydrolyzing -lactamase, KPC-1, from a carbapenem-resistant strain of klebsiella pneumoniae. Antimicrob Agents Chemother 20:440\u2013458.","DOI":"10.1128\/AAC.45.4.1151-1161.2001"},{"key":"395_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.15585\/mmwr.mm6723a4","volume":"67","author":"MS Walters","year":"2018","unstructured":"Walters MS, Witwer M, Lee Y-K, et al. Notes from the field: carbapenemase-producing carbapenem-resistant enterobacteriaceae from less common enterobacteriaceae genera\u2014United States, 2014\u20132017. MMWR Morb Mortal Wkly Rep. 2018;67:668\u20136695.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"395_CR35","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1086\/591861","volume":"29","author":"AI Hidron","year":"2008","unstructured":"Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006\u20132007. Infect Control Hosp Epidemiol. 2008;29:996\u20131011.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"395_CR36","doi-asserted-by":"crossref","unstructured":"Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009\u20132010. Infect Control Hosp Epidemiol 2013","DOI":"10.1086\/668770"},{"key":"395_CR37","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","volume":"37","author":"LM Weiner","year":"2016","unstructured":"Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011\u20132014. Infect Control Hosp Epidemiol. 2016;37:1288\u2013301.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"395_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/ofid\/ofx176","volume":"4","author":"B Cai","year":"2017","unstructured":"Cai B, Echols R, Magee G, et al. Prevalence of carbapenem-resistant gram-negative infections in the United States predominated by acinetobacter baumannii and pseudomonas aeruginosa. Open Forum Infect Dis. 2017;4:176.","journal-title":"Open Forum Infect Dis."},{"issue":"10","key":"395_CR39","doi-asserted-by":"publisher","first-page":"e00989","DOI":"10.1128\/AAC.00989-17","volume":"61","author":"K Nelson","year":"2017","unstructured":"Nelson K, Hemarajata P, Sun D, et al. Resistance to ceftazidime-avibactam is due to transposition of KPC in a porin-deficient strain of Klebsiella pneumoniae with increased efflux activity. Antimicrob Agents Chemother. 2017;61(10):e00989-e1017.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR40","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1128\/AAC.01165-15","volume":"59","author":"RM Humphries","year":"2015","unstructured":"Humphries RM, Yang S, Hemarajata P, et al. First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother. 2015;59:6605\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR41","doi-asserted-by":"publisher","first-page":"e02534","DOI":"10.1128\/AAC.02534-16","volume":"61","author":"G Haidar","year":"2017","unstructured":"Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MH. Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother. 2017;61:e02534-e2616.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR42","doi-asserted-by":"crossref","unstructured":"Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med 2019;","DOI":"10.1093\/jtm\/taz036"},{"issue":"10","key":"395_CR43","first-page":"3390","volume":"6","author":"F Codjoe","year":"2017","unstructured":"Codjoe F, Donkor E. Carbapenem resistance: a review. Med Sci. 2017;6(10):3390.","journal-title":"Med Sci."},{"key":"395_CR44","doi-asserted-by":"crossref","unstructured":"Souli M, Galani I, Antoniadou A, et al. An Outbreak of Infection due to \u03b2\u2010Lactamase Klebsiella pneumoniae Carbapenemase 2\u2013Producing K. pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes. Clin Infect Dis 2009; 50:364\u201373.","DOI":"10.1086\/649865"},{"key":"395_CR45","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Grajera I, Lara-Fuella N, Fern\u00e1ndez-Romero S, et al. (2016) R\u00e1pido aumento de la resistencia a cefalosporinas de 3 a generaci\u00f3n, imipenem y de la corresistencia en 7.140 aislados de Klebsiella pneumoniae en hemocultivos (2010\u20132014) seg\u00fan datos de EARS-Net en Espa\u00f1a. Enferm Infecc Microbiol Clin 35:480\u2013486.","DOI":"10.1016\/j.eimc.2016.06.007"},{"key":"395_CR46","unstructured":"CDC E. European Centre for Disease Prevention and Control (EARS-Net). Available at: https:\/\/ecdc.europa.eu\/en\/about-us\/partnerships-and-networks\/disease-and-laboratory-networks\/ears-net. Accessed 7 Feb 2019."},{"key":"395_CR47","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/jac\/dkx054","volume":"72","author":"A Baraniak","year":"2017","unstructured":"Baraniak A, Izdebski R, Zabicka D, et al. Multiregional dissemination of KPC-producing Klebsiella pneumoniae ST258\/ST512 genotypes in Poland, 2010\u201314. J Antimicrob Chemother. 2017;72:1610\u20136.","journal-title":"J Antimicrob Chemother."},{"key":"395_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/infdis\/jix524","volume":"217","author":"LJ Rojas","year":"2017","unstructured":"Rojas LJ, Weinstock GM, De La Cadena E, et al. An Analysis of the epidemic of klebsiella pneumoniae carbapenemase-producing K. pneumoniae: convergence of two evolutionary mechanisms creates the \u2018perfect storm.\u2019 J Infect Dis. 2017;217:82\u201392.","journal-title":"J Infect Dis."},{"key":"395_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1128\/AAC.01686-12","volume":"57","author":"C Lascols","year":"2013","unstructured":"Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JDD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013;57:130\u20136.","journal-title":"Antimicrob Agents Chemother."},{"key":"395_CR50","doi-asserted-by":"crossref","unstructured":"Ahlstrom CA, Ramey AM, Woksepp H, Bonnedahl J. Repeated Detection of carbapenemase-producing Escherichia coli in gulls inhabiting alaska. Antimicrob Agents Chemother 2019; 63.","DOI":"10.1128\/AAC.00758-19"},{"key":"395_CR51","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cmi.2018.04.004","volume":"24","author":"R K\u00f6ck","year":"2018","unstructured":"K\u00f6ck R, Daniels-Haardt I, Becker K, et al. Carbapenem-resistant Enterobacteriaceae in wildlife, food-producing, and companion animals: a systematic review. Clin Microbiol Infect. 2018;24:1241\u201350.","journal-title":"Clin Microbiol Infect."},{"issue":"10","key":"395_CR52","first-page":"2807","volume":"22","author":"BM Mahon","year":"2017","unstructured":"Mahon BM, Brehony C, McGrath E, et al. Indistinguishable NDM-producing Escherichia coli isolated from recreational waters, sewage, and a clinical specimen in Ireland, 2016 to 2017. Euro Surveill. 2017;22(10):2807.","journal-title":"Euro Surveill."},{"key":"395_CR53","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/jac\/dkx124","volume":"72","author":"Y Mani","year":"2017","unstructured":"Mani Y, Mansour W, Mammeri H, et al. KPC-3-producing ST167 Escherichia coli from mussels bought at a retail market in Tunisia. J Antimicrob Chemother. 2017;72:2403\u20134.","journal-title":"J Antimicrob Chemother."},{"key":"395_CR54","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1128\/AAC.02753-15","volume":"60","author":"CFM De Araujo","year":"2016","unstructured":"De Araujo CFM, Silva DM, Carneiro M, et al. Detection of carbapenemase genes in aquatic environments in Rio de Janeiro. Brazil Antimicrob Agents Chemother. 2016;60:4380\u20133.","journal-title":"Brazil Antimicrob Agents Chemother."},{"key":"395_CR55","doi-asserted-by":"crossref","unstructured":"Galler H, Feierl G, Petternel C, et al. KPC-2 and OXA-48 carbapenemase-harbouring Enterobacteriaceae detected in an Austrian wastewater treatment plant. Clin Microbiol Infect 2014; 20.","DOI":"10.1111\/1469-0691.12336"},{"key":"395_CR56","doi-asserted-by":"crossref","unstructured":"Martin A, Fahrbach K, Zhao Q, Lodise T. Association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to enterobacteriaceae: Results of a systematic literature review and meta-analysis. Open Forum Infect Dis 2018; 5:ofy150.","DOI":"10.1093\/ofid\/ofy150"},{"key":"395_CR57","doi-asserted-by":"crossref","unstructured":"Weir NJM, Pattison SH, Kearney P, et al. Criteria required for an acceptable point-of-care test for UTI detection: obtaining consensus using the Delphi technique. PLoS ONE 2018","DOI":"10.1371\/journal.pone.0198595"},{"key":"395_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijantimicag.2018.10.007","volume":"53","author":"KM Kazmierczak","year":"2019","unstructured":"Kazmierczak KM, Tsuji M, Wise MG, et al. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-\u03b2-lactamase-producing isolates (SIDERO-WT-2014. Int J Antimicrob Agents. 2019;53:177\u201384.","journal-title":"Int J Antimicrob Agents."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00395-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-020-00395-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00395-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:40:04Z","timestamp":1674902404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-020-00395-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1007\/s40121-020-00395-2","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}